Four more shows have been postponed at the ACT Arts Centre in Maple Ridge in response to fifth wave of the COVID-19 pandemic, propelled by the Omicron variant.
The shows were part of February programming at the Maple Ridge centre and their postponement comes after two shows were already postponed in January.
After the decision to reschedule the January performances, Curtis Pendleton, executive director of The ACT, said, like all businesses, they had to activate their COVID-19 plan and the measures they are taking now are exactly the same as the ones they enacted early in the pandemic.
“The measures have been activated to keep our staff and patrons as safe as possible during the current fifth wave and to preserve the operational capacity of The ACT,” said Pendleton.
The postponed shows, that were scheduled for February, include: City Opera Vancouver – A Night At The Opera With The Marx Brothers, The Bergmann Duo Oboe D’Amour, the National Theatre Encore Screening of Cyrano De Bergerac, and Cappella Borealis – Courtly Love: A Musical Tour Through Renaissance Europe.
READ MORE: Maple Ridge theatre postpones January shows due to COVID
ALSO: Proof of full vaccination needed to catch fall season at the ACT in Maple Ridge
The two shows in January have already been rescheduled. One, Two, Trio – Brass, part of the Coffee Concert series originally planned for Jan. 13, will now take place at 10:30 a.m. on May 6. And a performance by Rainbow Dance Theatre called Ilumidance has been rescheduled for 3 p.m. on Sunday, Apr. 10.
In addition to postponing the shows, the facility is now only open to registered participants and invited guests until further notice.
A notice on the centre’s website said performances are being rescheduled for later in the season and patrons are being contacted.
All other shows scheduled in March and onward are still scheduled as planned.
For more information about current health and safety protocols at the ACT go to theactmapleridge.org.
Have a story tip? Email: cflanagan@mapleridgenews.com
Like us on Facebook and follow us on Twitter.